Company Filing History:
Years Active: 2014-2016
Title: The Innovations of Makoto Urushitani
Introduction
Makoto Urushitani is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. His work focuses on addressing diseases associated with abnormalities in superoxide dismutase 1 (SOD1).
Latest Patents
Urushitani holds 2 patents related to his innovative research. His latest patents involve antibodies that specifically bind to abnormal SOD1, neutralizing its pathological effects when administered to humans. These monoclonal antibodies are produced by hybridoma cell lines, which were deposited with the International Depositary Authority of Canada on August 29, 2006. The applications of these antibodies extend to the treatment, prevention, and diagnosis of neurodegenerative diseases such as Amyotrophic lateral sclerosis, Parkinson's disease, and Alzheimer's disease.
Career Highlights
Urushitani is affiliated with Université Laval, where he continues to advance his research in biotechnology. His work has garnered attention for its potential impact on treating serious neurological conditions.
Collaborations
One of his notable collaborators is Jean-Pierre Julien, with whom he has worked on various research projects aimed at understanding and combating neurodegenerative diseases.
Conclusion
Makoto Urushitani's contributions to the field of biotechnology through his innovative patents highlight the importance of research in developing treatments for debilitating diseases. His work continues to inspire advancements in medical science.